{
    "clinical_study": {
        "@rank": "65628", 
        "arm_group": [
            {
                "arm_group_label": "Konjac Glucomannan", 
                "arm_group_type": "Experimental", 
                "description": "650g KJM-G"
            }, 
            {
                "arm_group_label": "Half Control/Half Konjac Glucomannan", 
                "arm_group_type": "Experimental", 
                "description": "325g KJM-G"
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention", 
                "description": "0g KJM-G"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess whether low caloric, low energy density, konjac food\n      products are effective in appetite regulation when administered as caloric replacements. It\n      is hypothesized that replacement of typical, balanced, vegetarian meals with konjac food\n      products will have comparable satiety scores, decreased postprandial glucose response, and\n      will not significantly affect subsequent food intake."
        }, 
        "brief_title": "Effects of Viscous Fibre Containing Foods on Satiety (Gel Form)", 
        "condition": "Obesity", 
        "condition_browse": {
            "mesh_term": "Obesity"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy, non-smoking males and females\n\n          -  Aged 18-70 years\n\n          -  BMI between 18 - 29.9 kg/m\u00b2\n\n          -  Non-dieters (1-10 score on Stunkard Eating Inventory)\n\n        Exclusion Criteria:\n\n          -  Known reported history of liver or kidney disease, diabetes, hypertension, stroke or\n             myocardial infarctions, thyroid disease, Celiac disease/gastrointestinal disease, or\n             AIDS\n\n          -  Weight change of +/- 3kg in the last 2 months\n\n          -  Alcohol intake >2 drinks/day\n\n          -  Inability to consume KJM-G meals\n\n          -  Any condition which might jeopardize the health and safety of the subject or study\n             personnel, or adversely affect the study results\n\n          -  Non-compliance with experimental procedures or safety guidelines"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 14, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02134938", 
            "org_study_id": "KJM-G"
        }, 
        "intervention": {
            "arm_group_label": [
                "Konjac Glucomannan", 
                "Half Control/Half Konjac Glucomannan"
            ], 
            "description": "Konjac Noodles (Wellbond Import Export Inc.), Vegan Konjac Shrimp (Sophie's Kitchen), Konjac Gel Cubes", 
            "intervention_name": "Konjac Glucomannan", 
            "intervention_type": "Dietary Supplement"
        }, 
        "intervention_browse": {
            "mesh_term": "(1-6)-alpha-glucomannan"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 7, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Toronto", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "M5C 2T2"
                }, 
                "name": "Clinical Risk Factor and Modification Centre"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "3", 
        "official_title": "Effects of High-Fibre, Low-Energy Density Viscous Gel Meals on Satiety, Appetite Regulation and Subsequent Food Intake in Healthy Individuals", 
        "overall_contact": {
            "email": "auyeungf@smh.ca", 
            "last_name": "Rodney Au-Yeung, BSc", 
            "phone": "(416) 864-6060", 
            "phone_ext": "5526"
        }, 
        "overall_official": [
            {
                "affiliation": "Risk Factor Modification Centre - St. Michael's Hospital", 
                "last_name": "Vladimir Vuksan, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Risk Factor Modification Centre - St. Michael's Hospital", 
                "last_name": "Alexandra Jenkins (Co-Investigator), RD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Department of Family Medicine - St. Michael's Hospital", 
                "last_name": "William Watson (Qualified Investigator), MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Subjects will record their subjective satiety ratings using a 100 mm visual analogue scale and these ratings will be combined into a total subjective appetite score using the formula (Q1+Q2+(100-Q3)+Q4)/4.", 
            "measure": "Subjective Satiety", 
            "safety_issue": "No", 
            "time_frame": "12 hours for each of the 3 study visits."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02134938"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Ambulatory Blood Pressure", 
                "safety_issue": "No", 
                "time_frame": "Measured at the beginning of each of the 3 study visits and every 30 minutes thereafter until 10:00pm the same day."
            }, 
            {
                "measure": "Height and Weight", 
                "safety_issue": "No", 
                "time_frame": "Taken once at the beginning of each of the 3 clinical visits."
            }, 
            {
                "description": "Capillary blood samples will be collected in anticoagulant containing tubes stored at -20\u00b0C and analyzed by trained personnel for plasma glucose concentration using the glucose oxidase method by YSI 2300 STAT Plus within 48 hours.", 
                "measure": "Blood Samples", 
                "safety_issue": "No", 
                "time_frame": "One sample taken immediately prior to (0min) eating each meal (Breakfast, Lunch, Snack and Dinner) and at 30, 60, 90 and 120 min after eating the Breakfast and Lunch meals for each of the 3 study visits (total of 12 blood samples per study visit)."
            }, 
            {
                "measure": "Palatability Scores", 
                "safety_issue": "No", 
                "time_frame": "Measured immediately after eating and finishing (<15min after the first bite) each meal (Breakfast, Lunch, Snack and Dinner) for each of the 3 study visits."
            }, 
            {
                "description": "Subjects will record their subjective food craving ratings, if any, prior to each meal, using a 100mm visual analogue scale.", 
                "measure": "Food Craving Rating", 
                "safety_issue": "No", 
                "time_frame": "Rated immediately prior (0min) to eating each meal (Breakfast, Lunch, Snack and Dinner) for each of the 3 study visits."
            }, 
            {
                "description": "Subjects will record their subsequent food intake from 12h to 24h post first meal. Food record will be analyzed with The Nutrition Food Processor (ESHA) and data will be tabulated and included as part of the cumulative daily food intake.", 
                "measure": "Subsequent Food Intake", 
                "safety_issue": "No", 
                "time_frame": "Recorded from the 12th to the 24th hour after beginning the first meal (Breakfast at 0min) for each of the 3 study visits."
            }
        ], 
        "source": "St. Michael's Hospital, Toronto", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "St. Michael's Hospital, Toronto", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}